Skip to content
healthcare.dev

OXAZEPAM

NDC 69315-913, OXAZEPAM, capsule, from Leading Pharma, LLC.

Product NDC
69315-913
Status
Listed
Labeler
Leading Pharma, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218261
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69315-913 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXAZEPAM30 mg/1

Pharmacologic classes

Benzodiazepine [EPC]; Benzodiazepines [CS]

Package NDCNDC-11Package
69315-913-0169315091301100 CAPSULE in 1 BOTTLE (69315-913-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/67f821fa-5663-4d69-82c9-5ee13a09f324
  • NADAC price for package 69315091301

    GET /v1/drugs/nadac/69315091301

Use it

Look up 69315-913 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69315-913 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69315-913. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.